Angiogenesis Inhibitors and Stimulators Market to Reach USD 67.17 Billion by 2032, Growing at 9.3% CAGR: Polaris Market Research Polaris Market Research reports that the global angiogenesis inhibitors and stimulators market was valued at USD 27.61 billion in 2022 and is projected to reach USD 67.17 billion by 2032, expanding at a CAGR of 9.3% during the forecast period. The report examines...